Home
/ Forbius
/ Competitors

Forbius Competitors and Similar CompaniesClear all

Forbius's competitors and similar companies include CytomX Therapeutics, Agios Pharmaceuticals and Bolt Biotherapeutics.

	Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.	CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.	Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.	Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
Founding Date	Founding Date 2011	Founding Date 2008	Founding Date 2008	Founding Date 2015
Type	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare bioengineering biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare drug development oncology pharma	Tags Technology biotech oncology platform therapy
Locations	Locations Austin, US HQ Montréal, CA	Locations South San Francisco, US HQ	Locations Cambridge, US HQ	Locations Redwood City, US HQ
Employees	Employees 811% decrease	Employees 15815% increase	Employees 53611% increase	Employees 5248% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 78 m	Valuation ($) 2.7 b	Valuation ($) 25.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $76.2m (FY, 2025)	Revenue (est.) $54m (FY, 2025)	Revenue (est.) $7.7m (FY, 2025)
Net income	Net income N/A	Net income ($17.4m) (FY, 2025)	Net income ($412.8m) (FY, 2025)	Net income ($33.4m) (FY, 2025)
Operating ⚠
Patents (US)	Patents (US) N/A	Patents (US) 13 (FY, 2016)	Patents (US) N/A	Patents (US) 1 (FY, 2020)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 132.4m	Total funding raised N/A	Total funding raised $ 177.5m